PL3079495T3 - Medykament i sposób leczenia chorób wrodzonej odpowiedzi immunologicznej - Google Patents
Medykament i sposób leczenia chorób wrodzonej odpowiedzi immunologicznejInfo
- Publication number
- PL3079495T3 PL3079495T3 PL14809872T PL14809872T PL3079495T3 PL 3079495 T3 PL3079495 T3 PL 3079495T3 PL 14809872 T PL14809872 T PL 14809872T PL 14809872 T PL14809872 T PL 14809872T PL 3079495 T3 PL3079495 T3 PL 3079495T3
- Authority
- PL
- Poland
- Prior art keywords
- medicament
- treating
- immune response
- innate immune
- response diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000015788 innate immune response Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C5/00—Other raw materials for the preparation of beer
- C12C5/004—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/62—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from Aspergillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21026—Prolyl oligopeptidase (3.4.21.26), i.e. proline-specific endopeptidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/23—Aspartic endopeptidases (3.4.23)
- C12Y304/23018—Aspergillopepsin I (3.4.23.18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/23—Aspartic endopeptidases (3.4.23)
- C12Y304/23019—Aspergillopepsin II (3.4.23.19)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/28—Hydrolysis, degree of hydrolysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Transplantation (AREA)
- Enzymes And Modification Thereof (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13196580.8A EP2883458A1 (fr) | 2013-12-11 | 2013-12-11 | Médicament et procédé pour traiter des maladies à réponse auto-immune |
PCT/EP2014/077355 WO2015086737A1 (fr) | 2013-12-11 | 2014-12-11 | Médicament et méthode de traitement de maladies à réponse immunitaire innée |
EP14809872.6A EP3079495B1 (fr) | 2013-12-11 | 2014-12-11 | Médicament et procédé pour traiter des maladies à réponse auto-immune |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3079495T3 true PL3079495T3 (pl) | 2020-04-30 |
Family
ID=49759104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14809872T PL3079495T3 (pl) | 2013-12-11 | 2014-12-11 | Medykament i sposób leczenia chorób wrodzonej odpowiedzi immunologicznej |
Country Status (10)
Country | Link |
---|---|
US (1) | US10413599B2 (fr) |
EP (2) | EP2883458A1 (fr) |
JP (1) | JP6862627B2 (fr) |
KR (1) | KR102341353B1 (fr) |
CN (1) | CN105813474A (fr) |
BR (1) | BR112016013072B1 (fr) |
ES (1) | ES2759065T3 (fr) |
PL (1) | PL3079495T3 (fr) |
RU (1) | RU2671832C1 (fr) |
WO (1) | WO2015086737A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4149520A4 (fr) * | 2020-05-12 | 2024-06-26 | Glutagen Pty Ltd | Méthodes et compositions pour la digestion d'ati |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK81193D0 (da) * | 1993-07-06 | 1993-07-06 | Novo Nordisk As | Enzym |
US6960462B2 (en) * | 2000-02-08 | 2005-11-01 | Dsm Ip Assets B.V | Use of acid-stable subtilisin proteases in animal feed |
RU15575U1 (ru) | 2000-05-25 | 2000-10-27 | Общество с ограниченной ответственностью Научно-производственная компания "КЕДР-89" | Установка для димеризации легких олефинов |
DK1572127T4 (da) * | 2002-02-14 | 2014-11-24 | Univ Leland Stanford Junior | Enzymbehandling af fødevarer til cøliaki |
US7320788B2 (en) * | 2002-02-14 | 2008-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
US7067124B2 (en) * | 2003-03-28 | 2006-06-27 | National Enzyme Company | Protease composition and method for treating a digestive disorder |
US8524225B2 (en) * | 2003-09-23 | 2013-09-03 | Dsm Ip Assets B.V. | Use of proline specific endoproteases to hydrolyse peptides and proteins |
US7628985B2 (en) * | 2004-04-26 | 2009-12-08 | The Board Of Regents Of The Leland Stanford Junior University | Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis |
WO2006097949A1 (fr) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Melange d’au moins 6 especes de bacteries de l'acide lactique et/ou bifidobacteria dans la facrication du levain |
WO2008115411A1 (fr) * | 2007-03-16 | 2008-09-25 | The Board Of Trustees Of The Leland Stanford Junior University | Thérapie enzymatique de combinaison pour la digestion de gluten diététique |
EP2229404A4 (fr) * | 2007-12-10 | 2011-03-09 | Univ Leland Stanford Junior | Polythérapie enzymatique pour la digestion gastrique de gluten alimentaire chez des patients souffrant de la maladie coeliaque |
WO2012146717A1 (fr) * | 2011-04-29 | 2012-11-01 | Dsm Ip Assets B.V. | Préparation d'une composition de blanc d'œuf |
-
2013
- 2013-12-11 EP EP13196580.8A patent/EP2883458A1/fr not_active Ceased
-
2014
- 2014-12-11 WO PCT/EP2014/077355 patent/WO2015086737A1/fr active Application Filing
- 2014-12-11 RU RU2016128070A patent/RU2671832C1/ru active
- 2014-12-11 KR KR1020167018205A patent/KR102341353B1/ko active IP Right Grant
- 2014-12-11 PL PL14809872T patent/PL3079495T3/pl unknown
- 2014-12-11 US US15/101,630 patent/US10413599B2/en active Active
- 2014-12-11 CN CN201480067431.8A patent/CN105813474A/zh active Pending
- 2014-12-11 JP JP2016536845A patent/JP6862627B2/ja active Active
- 2014-12-11 BR BR112016013072-3A patent/BR112016013072B1/pt active IP Right Grant
- 2014-12-11 ES ES14809872T patent/ES2759065T3/es active Active
- 2014-12-11 EP EP14809872.6A patent/EP3079495B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
EP3079495A1 (fr) | 2016-10-19 |
KR20160090396A (ko) | 2016-07-29 |
KR102341353B1 (ko) | 2021-12-21 |
RU2671832C1 (ru) | 2018-11-07 |
EP2883458A1 (fr) | 2015-06-17 |
EP3079495B1 (fr) | 2019-10-02 |
JP6862627B2 (ja) | 2021-04-21 |
BR112016013072B1 (pt) | 2021-06-01 |
WO2015086737A1 (fr) | 2015-06-18 |
JP2017504581A (ja) | 2017-02-09 |
CN105813474A (zh) | 2016-07-27 |
US10413599B2 (en) | 2019-09-17 |
BR112016013072A2 (pt) | 2018-05-22 |
ES2759065T3 (es) | 2020-05-07 |
US20160346364A1 (en) | 2016-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222530A1 (zh) | 用於皮膚處理的微閉合及相關方法 | |
HK1225305A1 (zh) | 治療腦疾病的方法和組合物 | |
HK1220418A1 (zh) | 治療呼吸系統疾病的方法及為此而製的製劑 | |
HK1215681A1 (zh) | 使用白細胞介素- 治療疾病和病症的方法 | |
EP2999474A4 (fr) | Thérapeutique et procédé d'utilisation | |
IL244317B (en) | Cortistatin analogs for the treatment of inflammatory and/or immune diseases | |
EP2943189A4 (fr) | Procédés et compositions pour le traitement de maladies de démyélinisation | |
SG11201604626VA (en) | Medicament apparatus and method | |
HK1215373A1 (zh) | 用於治療代謝疾病的方法和裝置 | |
EP2953678A4 (fr) | Cathéter et procédé de transfert de substance thérapeutique | |
EP3079766A4 (fr) | Dispositif et procédé de traitement par la méditation | |
EP3020478A4 (fr) | Catalyseur de polyoxométalate haute performance et son procédé de préparation | |
EP3053610A4 (fr) | Filtre de traitement du sang et procédé de traitement du sang | |
SG11201601684PA (en) | Medical apparatus and method | |
IL246286B (en) | A medical preparation for the prevention and treatment of advanced myopia. | |
EP2968452A4 (fr) | Compositions et procédés pour traiter une maladie rétinienne | |
IL248962A0 (en) | Device and method for administering drugs to the brain | |
IL241096B (en) | Treatment methods | |
PL3079495T3 (pl) | Medykament i sposób leczenia chorób wrodzonej odpowiedzi immunologicznej | |
EP3015112A4 (fr) | Médicament pour le traitement de l'ascite hépatique, et son procédé de préparation | |
IL245675A0 (en) | Therapeutic regimen and method for treating type 2 diabetes | |
IL227344A0 (en) | A method for increasing drug effectiveness and reducing side effects | |
EP2970152A4 (fr) | Préparation et procédé d'utilisation pour traiter des maladies respiratoires | |
ZA201302565B (en) | Methods for treating hyperuricemia and related diseases | |
GB201309001D0 (en) | Methods for prevention and treatment of preeclampsia |